Cited by 52Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cognitive therapy for anxious depression in STAR(*) D: what have we learned?

Open access
Farabaugh, Amy, Alpert, Jonathan, Wisniewski, Stephen R., Otto, Michael W., Fava, Maurizio, Baer, Lee, Perlis, Roy, Friedman, Ed +6 more·2012·Journal of Affective Disorders

Abstract

Background Anxious depression, defined as MDD with high levels of anxiety symptoms, has been associated with lower rates of antidepressant response and remission as well as greater chronicity, suicidality and antidepressant side-effect burden. The primary aim of this study was to assess the effectiveness of cognitive therapy (CT) alone or in combination with medications for anxious versus non-anxious depression.Methods We assessed the STAR(⁎)D study participants who were partial or non-responders to citalopram. Subjects were then either switched (n=696) to a new antidepressant or to CT alone, or they were kept on citalopram and augmented (n=577) with another antidepressant or CT. We compared response and remission rates, across treatment conditions, between those who met criteria for anxious depression and those who did not.Results Those with anxious depression had significantly lower remission rates based on the QIDS, whether assigned to switch or augmentation, compared to those with non-anxious depression. Those with anxious depression, compared to those without, had significantly lower response rates based on the QIDS only in the switch group. There was no significant interaction between anxious depression and treatment assignment.Limitations Limitations include the use of citalopram as the only Level 1 pharmacotherapy and medication augmentation option, the relatively small size of the CT arms, use of depression-focused CT rather than anxiety-focused CT, and focus on acute treatment outcomes.Conclusions Individuals with anxious depression appear to experience higher risk of poorer outcome following pharmacotherapy and/or CT after an initial course of citalopram and continued efforts to target this challenging form of depression are needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2012.04.029

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • When generalized anxiety disorder and major depressive disorder co-occur, subjective distress and functional impairment may be greater and treatment response may be worse.

    “When co-occurring, the subjective distress and functional impairment may be even larger, and the treatment response worse (Farabaugh et al., 2012; Newman, Przeworski, Fisher, & Borkovec, 2010; Olatunji, Cisler, & Deacon, 2010).”

    From Changes in Decentering and Reappraisal Temporally Precede Symptom Reduction During Emotion Regulation Therapy for Generalized Anxiety Disorder With and Without Co-Occurring Depression. (2019) · cites this paper as Farabaugh et al., 2012

    The Introduction defines anxious depression broadly as MDD with either a co-occurring anxiety disorder or high anxiety symptoms, and the Discussion reports poorer treatment response in that group than in patients with depression alone. The paper does not establish that result specifically for co-occurring generalized anxiety disorder and MDD, nor does it report greater subjective distress or functional impairment for that pairing. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Farabaugh, A., Alpert, J., Wisniewski, S. R., Otto, M. W., Fava, M., Baer, L., Perlis, R., Friedman, E., Nyer, M., Bitran, S., Balasubramani, G. K., Inamori, A., Trivedi, M., & Thase, M. E.
Affiliations
  • Massachusetts General Hospital (US)
  • Harvard University (US)
  • University of Pittsburgh (US)
  • Boston University (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Farabaugh, Amy
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2012-12
Volume
142
Issue
1-3
Pages
213-218
ISSN
0165-0327 (ISSN-L)
OpenAlex
W1985073203
Cited by
52
References
39
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 3 · 2017: 1 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 3
FWCI
3.05
Type
journal article
Language
en
Open access
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Mental Health (MH-90003)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
anxious depression, cognitive therapy, STAR*D, citalopram, antidepressant response, remission, treatment switching, antidepressant augmentation, major depressive disorder, anxiety comorbidity, treatment outcomes
MeSH terms
Adult, Antidepressive Agents, Anxiety Disorders, Major Depressive Disorder, Female, Humans, Longitudinal Studies, Male, Remission Induction, Citalopram, Comorbidity, Cognitive Behavioral Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review